Medical Assistant at Tui Medical, Rototuna at Time of Data Collection, Taranaki Base Hospital,New Plymouth, New Zealand.
General Practitioner, GP at Tui Medical, Rototuna at Time of Data Collection, TuiOra Family Health, New Plymouth, New Zealand.
Prim Health Care Res Dev. 2023 Jun 20;24:e43. doi: 10.1017/S1463423623000294.
Diabetes mellitus is associated with an increased risk of depression. Appropriate screening and treatment of depression may therefore support diabetes management in primary care. Study aim was to review the efficacy of using a Patient Health Questionnaire - (PHQ-9) tool to screen for depression in patients with type 2 diabetes mellitus (T2DM) in New Zealand.It was a cross-sectional study that included 100 consecutive patients with T2DM from two urban practices in Hamilton, New Zealand. Patients were screened using PHQ-9 scores.Using the PHQ-9, the overall prevalence of depression was 29% including 11 patients under active management/prescribing for depression and 18 undiagnosed patients. By ethnicity, depression affected 41.3%, 33.0%, 25.0% and 13.3% of NZ European, Māori, Pacific and other ethnicities, respectively. PHQ-9 scoring is an easy to administer tool that can be used to screen for unrecognized depression in patients with diabetes as a part of an annual diabetic review.
糖尿病与抑郁症的风险增加有关。因此，在初级保健中适当筛查和治疗抑郁症可能有助于糖尿病的管理。本研究旨在回顾在新西兰使用患者健康问卷-9（PHQ-9）工具筛查 2 型糖尿病（T2DM）患者抑郁症的疗效。这是一项横断面研究，包括来自新西兰汉密尔顿的两家城市诊所的 100 例连续 T2DM 患者。患者使用 PHQ-9 评分进行筛查。使用 PHQ-9，抑郁症的总体患病率为 29%，包括 11 例正在积极管理/开处抑郁症药物的患者和 18 例未确诊的患者。按族裔划分，抑郁症分别影响新西兰欧洲人、毛利人、太平洋岛民和其他族裔的 41.3%、33.0%、25.0%和 13.3%。PHQ-9 评分是一种易于管理的工具，可用于筛查糖尿病患者中未被识别的抑郁症，作为年度糖尿病检查的一部分。
